Firefox 145 has arrived with new features, enhanced privacy protection, and the end of support for 32-bit Linux systems.
22hon MSN
First-in-human trial of CRISPR gene-editing therapy safely lowers cholesterol and triglycerides
In a 15-patient, Phase 1, first-in-human trial, a one-time CRISPR-Cas9 gene-editing therapy safely reduced LDL cholesterol ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback